Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Capital Expenditures (2016 - 2026)

Iradimed has reported Capital Expenditures over the past 14 years, most recently at $403000.0 for Q1 2026.

  • Quarterly Capital Expenditures fell 89.1% to $403000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.6 million through Mar 2026, down 123.08% year-over-year, with the annual reading at $656000.0 for FY2025, 91.81% down from the prior year.
  • Capital Expenditures was $403000.0 for Q1 2026 at Iradimed, up from -$6.8 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $6.4 million in Q1 2023 and troughed at -$6.8 million in Q4 2025.
  • The 5-year median for Capital Expenditures is $270566.0 (2024), against an average of $628390.3.
  • Year-over-year, Capital Expenditures plummeted 3314.03% in 2023 and then surged 3620.2% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $213540.0 in 2022, then crashed by 52.74% to $100913.0 in 2023, then surged by 2664.9% to $2.8 million in 2024, then plummeted by 344.25% to -$6.8 million in 2025, then soared by 105.91% to $403000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Capital Expenditures are $403000.0 (Q1 2026), -$6.8 million (Q4 2025), and $1.1 million (Q3 2025).